Literature DB >> 32392494

Sample sizes in COVID-19-related research.

Paul H Lee1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32392494      PMCID： PMC7207191          DOI： 10.1503/cmaj.75308

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  A simple approximation for calculating sample sizes for comparing independent proportions.

Authors:  J L Fleiss; A Tytun; H K Ury
Journal:  Biometrics       Date:  1980-06       Impact factor: 2.571

2.  Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic.

Authors:  Matthew P Cheng; Todd C Lee; Darrell H S Tan; Srinivas Murthy
Journal:  CMAJ       Date:  2020-03-26       Impact factor: 8.262

3.  High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial.

Authors:  Cai-Neng Wu; Lin-Zhi Xia; Kun-Hong Li; Wu-Hua Ma; Dong-Nan Yu; Bo Qu; Bi-Xi Li; Ying Cao
Journal:  Br J Anaesth       Date:  2020-03-20       Impact factor: 9.166

4.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Authors:  Philippe Gautret; Jean-Christophe Lagier; Philippe Parola; Van Thuan Hoang; Line Meddeb; Morgane Mailhe; Barbara Doudier; Johan Courjon; Valérie Giordanengo; Vera Esteves Vieira; Hervé Tissot Dupont; Stéphane Honoré; Philippe Colson; Eric Chabrière; Bernard La Scola; Jean-Marc Rolain; Philippe Brouqui; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-20       Impact factor: 5.283

5.  Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial.

Authors:  Yuan-Yuan Qin; Yi-Hong Zhou; Yan-Qiu Lu; Feng Sun; Sen Yang; Vijay Harypursat; Yao-Kai Chen
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

6.  A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.

Authors:  Bin Cao; Yeming Wang; Danning Wen; Wen Liu; Jingli Wang; Guohui Fan; Lianguo Ruan; Bin Song; Yanping Cai; Ming Wei; Xingwang Li; Jiaan Xia; Nanshan Chen; Jie Xiang; Ting Yu; Tao Bai; Xuelei Xie; Li Zhang; Caihong Li; Ye Yuan; Hua Chen; Huadong Li; Hanping Huang; Shengjing Tu; Fengyun Gong; Ying Liu; Yuan Wei; Chongya Dong; Fei Zhou; Xiaoying Gu; Jiuyang Xu; Zhibo Liu; Yi Zhang; Hui Li; Lianhan Shang; Ke Wang; Kunxia Li; Xia Zhou; Xuan Dong; Zhaohui Qu; Sixia Lu; Xujuan Hu; Shunan Ruan; Shanshan Luo; Jing Wu; Lu Peng; Fang Cheng; Lihong Pan; Jun Zou; Chunmin Jia; Juan Wang; Xia Liu; Shuzhen Wang; Xudong Wu; Qin Ge; Jing He; Haiyan Zhan; Fang Qiu; Li Guo; Chaolin Huang; Thomas Jaki; Frederick G Hayden; Peter W Horby; Dingyu Zhang; Chen Wang
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245
  6 in total
  1 in total

1.  Hematological- and Immunological-Related Biomarkers to Characterize Patients with COVID-19 from Other Viral Respiratory Diseases.

Authors:  Rafael Suárez-Del-Villar-Carrero; Diego Martinez-Urbistondo; Amanda Cuevas-Sierra; Iciar Ibañez-Sustacha; Alberto Candela-Fernandez; Andrea Dominguez-Calvo; Omar Ramos-Lopez; Juan Antonio Vargas; Guillermo Reglero; Paula Villares-Fernandez; Jose Alfredo Martinez
Journal:  J Clin Med       Date:  2022-06-21       Impact factor: 4.964
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.